Nasdaq · CIK 0001856725
RANI Rani Therapeutics Holdings, Inc.
Insider trading from SEC Form 4. Last filing 13 d ago. Close $0.80 on Oct 9, 2026, +74% from the 52-week low and -72% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
13
with a Form 4 at this company
Price and insider trades, last year
RANIOct 9, 2026 · close 0.80
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Rani Therapeutics Holdings, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 36Weak | Kate McKinley Chief Business Officer buy | $30k 17,960 shares | - | - | |
| 33Weak | Talat Imran Chief Executive Officer buy | $20k 10,296 shares | +2% | - | |
| 47Moderate | South Cone Investments Limited Partnership owner sell | $10M 3,829,360 shares | -32% | - |
Transactions
The last 41 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 27, 2026 | Alireza Javadi Chief Technical Officer | FTax withholding Class A Common Stock | -309 | $0.76 | $235 | 9,071 | 13 d ago |
| Sep 27, 2026 | Talat Imran Chief Executive Officer | FTax withholding Class A Common Stock | -7,928 | $0.76 | $6,019 | 461,808 | 13 d ago |
| Aug 1, 2025 | Kate McKinley Chief Business Officer | AGrant or award Employee Stock Option (Right to Buy)derivative | +120,000 | $0.00 | $0 | 120,000 | Aug 5, 2025 |
| May 28, 2025 | Dennis A Ausiello director | AGrant or award Director Stock Option (Right to Buy)derivative | +50,000 | $0.00 | $0 | 50,000 | May 30, 2025 |
| May 28, 2025 | Jean Luc Butel director | AGrant or award Director Stock Option (Right to Buy)derivative | +50,000 | $0.00 | $0 | 50,000 | May 30, 2025 |
| May 28, 2025 | Andrew Farquharson director | AGrant or award Director Stock Option (Right to Buy)derivative | +50,000 | $0.00 | $0 | 50,000 | May 30, 2025 |
| May 28, 2025 | Mir A Imran director | AGrant or award Director Stock Option (Right to Buy)derivative | +50,000 | $0.00 | $0 | 50,000 | May 30, 2025 |
| May 28, 2025 | Maulik Nanavaty director | AGrant or award Director Stock Option (Right to Buy)derivative | +50,000 | $0.00 | $0 | 50,000 | May 30, 2025 |
| May 28, 2025 | Lisa Ann Rometty director | AGrant or award Director Stock Option (Right to Buy)derivative | +50,000 | $0.00 | $0 | 50,000 | May 30, 2025 |
| May 23, 2025 | Mir Hashim Chief Scientific Officer | AGrant or award Stock Option (Right to Buy)derivative | +325,000 | $0.00 | $0 | 325,000 | May 23, 2025 |
| May 23, 2025 | Talat Imran Chief Executive Officer | AGrant or award Stock Option (Right to Buy)derivative | +1,053,000 | $0.00 | $0 | 1,053,000 | May 23, 2025 |
| May 23, 2025 | Kate McKinley Chief Business Officer | AGrant or award Stock Option (Right to Buy)derivative | +325,000 | $0.00 | $0 | 325,000 | May 23, 2025 |
| May 23, 2025 | Svai S Sanford Chief Financial Officer | AGrant or award Stock Option (Right to Buy)derivative | +325,000 | $0.00 | $0 | 325,000 | May 23, 2025 |
| Dec 16, 2024 | Maulik Nanavaty director | DDisposition to issuer Stock Option (Right to Buy)derivative | -101,276 | - | - | 0 | Dec 17, 2024 |
| Dec 16, 2024 | Mir A Imran director | DDisposition to issuer Stock Option (Right to Buy)derivative | -101,276 | - | - | 0 | Dec 17, 2024 |
| Dec 16, 2024 | Andrew Farquharson director | DDisposition to issuer Stock Option (Right to Buy)derivative | -101,276 | - | - | 0 | Dec 17, 2024 |
| Dec 16, 2024 | Laureen Debuono director | DDisposition to issuer Stock Option (Right to Buy)derivative | -101,276 | - | - | 0 | Dec 17, 2024 |
| Dec 16, 2024 | Lisa Ann Rometty director | DDisposition to issuer Stock Option (Right to Buy)derivative | -101,276 | - | - | 0 | Dec 17, 2024 |
| Dec 16, 2024 | Jean Luc Butel director | DDisposition to issuer Stock Option (Right to Buy)derivative | -101,276 | - | - | 0 | Dec 17, 2024 |
| Dec 16, 2024 | Dennis A Ausiello director | DDisposition to issuer Stock Option (Right to Buy)derivative | -101,276 | - | - | 0 | Dec 17, 2024 |
| Dec 16, 2024 | Jean Luc Butel director | AGrant or award Stock Option (Right to Buy)derivative | +101,276 | - | - | 101,276 | Dec 17, 2024 |
| Dec 16, 2024 | Laureen Debuono director | AGrant or award Stock Option (Right to Buy)derivative | +101,276 | - | - | 101,276 | Dec 17, 2024 |
| Dec 16, 2024 | Andrew Farquharson director | AGrant or award Stock Option (Right to Buy)derivative | +101,276 | - | - | 101,276 | Dec 17, 2024 |
| Dec 16, 2024 | Dennis A Ausiello director | AGrant or award Stock Option (Right to Buy)derivative | +101,276 | - | - | 101,276 | Dec 17, 2024 |
| Dec 16, 2024 | Mir A Imran director | AGrant or award Stock Option (Right to Buy)derivative | +101,276 | - | - | 101,276 | Dec 17, 2024 |
| Dec 16, 2024 | Maulik Nanavaty director | AGrant or award Stock Option (Right to Buy)derivative | +101,276 | - | - | 101,276 | Dec 17, 2024 |
| Dec 16, 2024 | Lisa Ann Rometty director | AGrant or award Stock Option (Right to Buy)derivative | +101,276 | - | - | 101,276 | Dec 17, 2024 |
| Dec 16, 2024 | Jean Luc Butel director | DDisposition to issuer Stock Option (Right to Buy)derivative | -18,875 | - | - | 0 | Dec 17, 2024 |
| Dec 16, 2024 | Laureen Debuono director | DDisposition to issuer Stock Option (Right to Buy)derivative | -18,875 | - | - | 0 | Dec 17, 2024 |
| Dec 16, 2024 | Lisa Ann Rometty director | DDisposition to issuer Stock Option (Right to Buy)derivative | -17,708 | - | - | 0 | Dec 17, 2024 |
| Dec 16, 2024 | Dennis A Ausiello director | DDisposition to issuer Stock Option (Right to Buy)derivative | -15,423 | - | - | 0 | Dec 17, 2024 |
| Dec 16, 2024 | Maulik Nanavaty director | DDisposition to issuer Stock Option (Right to Buy)derivative | -15,423 | - | - | 0 | Dec 17, 2024 |
| Dec 16, 2024 | Lisa Ann Rometty director | AGrant or award Stock Option (Right to Buy)derivative | +17,708 | - | - | 49,037 | Dec 17, 2024 |
| Dec 16, 2024 | Jean Luc Butel director | AGrant or award Stock Option (Right to Buy)derivative | +18,875 | - | - | 135,896 | Dec 17, 2024 |
| Dec 16, 2024 | Maulik Nanavaty director | AGrant or award Stock Option (Right to Buy)derivative | +15,423 | - | - | 79,317 | Dec 17, 2024 |
| Dec 16, 2024 | Laureen Debuono director | AGrant or award Stock Option (Right to Buy)derivative | +18,875 | - | - | 135,896 | Dec 17, 2024 |
| Dec 16, 2024 | Dennis A Ausiello director | AGrant or award Stock Option (Right to Buy)derivative | +15,423 | - | - | 79,317 | Dec 17, 2024 |
| Dec 13, 2024 | Kate McKinley Chief Business Officer | POpen-market purchase Class A Common Stock | +17,960 | $1.67 | $30k | 17,960 | Dec 16, 2024 |
| Dec 9, 2024 | Talat Imran Chief Executive Officer | POpen-market purchase Class A Common Stock | +10,296 | $1.94 | $20k | 494,751 | Dec 10, 2024 |
| Oct 15, 2024 | South Cone Investments Limited Partnership owner | SOpen-market sale Class A Common Stockindirect: Shares indirectly held through South Lake One LLC | -3,305,622 | $2.55 | $8.4M | 8,825,932 | Oct 17, 2024 |
| Oct 15, 2024 | South Cone Investments Limited Partnership owner | SOpen-market sale Class A Common Stockindirect: Shares indirectly held through South Lake One LLC | -523,738 | $3.26 | $1.7M | 8,302,194 | Oct 17, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Dennis A Ausiellodirector
- Jean Luc Buteldirector
- Laureen Debuonodirector
- Andrew Farquharsondirector
- Mir HashimChief Scientific Officer
- Mir A Imrandirector
- Talat ImranChief Executive Officer
- Alireza JavadiChief Technical Officer
- Kate McKinleyChief Business Officer
- Maulik Nanavatydirector
- Lisa Ann Romettydirector
- Svai S SanfordChief Financial Officer
- South Cone Investments Limited Partnershipowner
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.